Publication of a Prospectus

RNS Number : 7963E
IG Group Holdings plc
31 October 2022
 

 

IG Group Holdings plc

31 October 2022

Publication of Prospectus

 

 

The following Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

Base prospectus dated 31 October 2022 (the "Prospectus") relating to the £1,000,000,000 Euro Medium Term Note Programme of IG Group Holdings plc.

 

To view the Prospectus, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/7963E_1-2022-10-31.pdf

 

A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

 

Deputy Company Secretary

Aurelia Gibbs 

cosec@ig.com

+44 20 7896 0011

 

Investors contact

Richard Heading   

investors@ig.com

 

+44 20 7573 0742

IG Group Press

Alayna Francis       

press@ig.com

 

+44 20 7896 0011

FTI Consulting

Ed Berry / Katherine Bell

iggroup.sc@fticonsulting.com

+44 77 0333 0199 / +44 79 7687 0961

 


Disclaimer - Intended Addressees

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, this announcement and the Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIQFLFXLBLZFBK
UK 100

Latest directors dealings